C12Y 103/08006
Glutaryl-coa dehydrogenase
Official title: Glutaryl-CoA dehydrogenase (1.3.8.6)
C12Y103/08006 (Glutaryl-coa dehydrogenase) appears on 1 US grants and 6 published applications in this corpus.
Search patents in C12Y- Granted patents
- 1
- Published applications
- 6
- Assignees
- 6
- Inventors
- 20
- Latest grant
- 9 Dec 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2021 | 0 | 2 |
| 2022 | 0 | 0 |
| 2023 | 0 | 1 |
| 2024 | 0 | 1 |
| 2025 | 1 | 1 |
| 2026 | 0 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Production of cannabinoids and engineered cells therefor23 Jul 2026US 2026/0209780 A1Cellibre, Inc.
- Recombinant aav vectors for treating glutaric aciduria type i27 Feb 2025US 2025/0064982 A1Shanghai Vitalgen Biopharma Co., Ltd.
- Inhibition of glutaryl-coa dehydrogenase for the treatment of melanoma19 Dec 2024US 2024/0417736 A1Sanford Burnham Prebys Medical Discovery Institute
- Composition for treatment of glutaric aciduria and administration method therefor6 Jul 2023US 2023/0210959 A1Novel Pharma Inc.
- Embryonic zebrafish models using dnazyme mediated knockdown28 Jan 2021US 2021/0022324 A1
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.